| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.035 | 0.4 |